ABBVON

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

MenoABBVON

PozíciaNo.3332

Trhová kapitalizácia$0.00

Plne zriedená trhová hodnota$0.00

Podiel na trhu%

Objem obchodovania/trhová kapitalizácia (24 h)896,557.09%

Počet coinov v obehu125.77024904

Max. počet coinov v obehu0

Celková ponuka125.77024904

Rýchlosť obehu%

Dátum vydania--

Cena, za ktorú bolo aktívum prvýkrát vydané--

Celkové maximum237.64005999136555,2026-03-05

Najnižšia cena193.3720963640878,2026-04-29

Verejný blockchainETH

ÚvodAbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

Sektor

Sociálne siete

• Oficiálna webová stránka
• Prieskumník blokov

etfindex:mc_etfindex_sourceOdmietnutie zodpovednosti: Údaje, ktoré poskytuje cmc a ktoré by sa nemali považovať za investičné poradenstvo.